Literature DB >> 34019233

Anti-SARS-CoV-2 IgY Isolated from Egg Yolks of Hens Immunized with Inactivated SARS-CoV-2 for Immunoprophylaxis of COVID-19.

Haiyan Shen1, Yanxing Cai2, Huan Zhang3, Jie Wu3, Lin Ye4, Penghui Yang5, Xiaojun Lin6, Shibo Jiang7, Ming Liao8.   

Abstract

Entities:  

Year:  2021        PMID： 34019233     DOI： 10.1007/s12250-021-00371-1

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  1 in total

1.  Learning from the past: development of safe and effective COVID-19 vaccines.

Authors:  Shan Su; Lanying Du; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2020-10-16       Impact factor: 78.297
  1 in total
  8 in total

1.  Egg-Derived Anti-SARS-CoV-2 Immunoglobulin Y (IgY) With Broad Variant Activity as Intranasal Prophylaxis Against COVID-19.

Authors:  Lyn R Frumkin; Michaela Lucas; Curtis L Scribner; Nastassja Ortega-Heinly; Jayden Rogers; Gang Yin; Trevor J Hallam; Alice Yam; Kristin Bedard; Rebecca Begley; Courtney A Cohen; Catherine V Badger; Shawn A Abbasi; John M Dye; Brian McMillan; Michael Wallach; Traci L Bricker; Astha Joshi; Adrianus C M Boon; Suman Pokhrel; Benjamin R Kraemer; Lucia Lee; Stephen Kargotich; Mahima Agochiya; Tom St John; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

2.  Preclinical Assessment of IgY Antibodies Against Recombinant SARS-CoV-2 RBD Protein for Prophylaxis and Post-Infection Treatment of COVID-19.

Authors:  Andres Agurto-Arteaga; Astrid Poma-Acevedo; Dora Rios-Matos; Ricardo Choque-Guevara; Ricardo Montesinos-Millán; Ángela Montalván; Gisela Isasi-Rivas; Yudith Cauna-Orocollo; María de Grecia Cauti-Mendoza; Norma Pérez-Martínez; Kristel Gutierrez-Manchay; Ingrid Ramirez-Ortiz; Dennis Núñez-Fernández; Mario I Salguedo-Bohorquez; Stefany Quiñones-Garcia; Manolo Fernández Díaz; Luis A Guevara Sarmiento; Mirko Zimic
Journal:  Front Immunol       Date:  2022-05-10       Impact factor: 8.786

3.  Are Hamsters a Suitable Model for Evaluating the Immunogenicity of RBD-Based Anti-COVID-19 Subunit Vaccines?

Authors:  Iuliia A Merkuleva; Dmitry N Shcherbakov; Mariya B Borgoyakova; Anastasiya A Isaeva; Valentina S Nesmeyanova; Natalia V Volkova; Vazirbek S Aripov; Daniil V Shanshin; Larisa I Karpenko; Svetlana V Belenkaya; Elena I Kazachinskaia; Ekaterina A Volosnikova; Tatiana I Esina; Alexandr A Sergeev; Kseniia A Titova; Yulia V Konyakhina; Anna V Zaykovskaya; Oleg V Pyankov; Evgeniia A Kolosova; Olesya E Viktorina; Arseniya A Shelemba; Andrey P Rudometov; Alexander A Ilyichev
Journal:  Viruses       Date:  2022-05-16       Impact factor: 5.818

4.  Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker.

Authors:  Lirong Bao; Cheng Zhang; Jinglu Lyu; Ping Yi; Xin Shen; Boyu Tang; Hang Zhao; Biao Ren; Yu Kuang; Linlin Zhou; Yan Li
Journal:  J Appl Microbiol       Date:  2021-11-03       Impact factor: 4.059

5.  Specific anti-SARS-CoV-2 S1 IgY-scFv is a promising tool for recognition of the virus.

Authors:  Shikun Ge; Rao Wu; Tingting Zhou; Xiang Liu; Jin Zhu; Xiaoying Zhang
Journal:  AMB Express       Date:  2022-02-12       Impact factor: 3.298

6.  SARS-CoV-2-specific immunoglobulin Y antibodies are protective in infected mice.

Authors:  Sherif A El-Kafrawy; Abby Odle; Aymn T Abbas; Ahmed M Hassan; Umama A Abdel-Dayem; Arooj K Qureshi; Lok-Yin Roy Wong; Jian Zheng; David K Meyerholz; Stanley Perlman; Alimuddin Zumla; Esam I Azhar
Journal:  PLoS Pathog       Date:  2022-09-19       Impact factor: 7.464

7.  Preclinical Evaluation of Chicken Egg Yolk Antibody (IgY) Anti-RBD Spike SARS-CoV-2-A Candidate for Passive Immunization against COVID-19.

Authors:  Hendris Wongso; Isa Mahendra; Wyanda Arnafia; Idar Idar; Muhammad Yusuf; Arifudin Achmad; Holis A Holik; Ahmad Kurniawan; Iim Halimah; Maula E Sriyani; Teguh H A Wibawa; Muhamad B Febrian; Yanuar Setiadi; Eva M Widyasari; Isti Daruwati; Crhisterra E Kusumaningrum; Toto Subroto
Journal:  Vaccines (Basel)       Date:  2022-01-17

Review 8.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.